04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
An empirical analysis of 128 M&A transactions provides food for thought about whether the economic d...
Read More >
Construction disputes often involve voluminous amounts of discovery, including documents in the hand...
Read More >
The Payroll Protection Program has been a lifesaver to many businesses this year, but its quick roll...
Read More >
With the California legislative year now closed, we know which proposals became reality and offer in...
Read More >
In early January, California truck drivers and transportation companies breathed a collective sigh o...
Read More >
When prospecting potential clients that are considering a new 401(k) plan, push those tax credits if...
Read More >